IMMUNOCELLULAR THERAPEUTICS (IMUC) Stock Technical Analysis
USA - NYSEARCA:IMUC - US4525362046
We assign a technical rating of 0 out of 10 to IMUC. IMUC scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
The technical rating of IMUC is bad and it also does not present a quality setup at the moment. Prices have been extended to the downside lately. For a nice entry it is better to wait for a consolidation.
More info and screens
0.05
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for IMUC is down. |
| ChartMill Short Term Trend Indicator | NEUTRAL | NEUTRAL | The short term trend for IMUC is neutral. |
| ChartMill Relative Strength | 0.33 | NEGATIVE | IMUC has a low relative strength, it was outperformed by 99.67% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of IMUC is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of IMUC is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | DOWN | NEGATIVE | The current price of IMUC is below a declining SMA(200). |
| Relative Strength Index/RSI (14) | 14.95 | OVERSOLD | The low RSI value suggests IMUC may be oversold. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.01 | NEGATIVE | The MACD value suggests IMUC has a negative trend. |
| Stochastics (14,3) | 31.85 | NEUTRAL | The Stochastics value for IMUC is a neutral value. |
| Average True Range in percent/ATR (20) | 49.25 | HIGH VOLATILITY | The high ATR as a percentage value for IMUC suggests high volalility. |
NYSEARCA:IMUC (10/16/2018, 8:13:46 PM)
0.053
-0.17 (-75.91%)
IMMUNOCELLULAR THERAPEUTICS / IMUC FAQ
What is the technical rating for IMUC stock?
ChartMill assigns a technical rating of 0 / 10 to IMUC.
What is the current trend direction of IMMUNOCELLULAR THERAPEUTICS (IMUC) stock?
The current trend direction for IMMUNOCELLULAR THERAPEUTICS (IMUC) is Bearish.
Can you provide the RSI signal for IMMUNOCELLULAR THERAPEUTICS?
IMMUNOCELLULAR THERAPEUTICS (IMUC) has an RSI value of 14.9488. This indicates that the stock is currently oversold.
Can you provide the short term momentum for IMMUNOCELLULAR THERAPEUTICS?
The short term momentum for IMMUNOCELLULAR THERAPEUTICS (IMUC) is neutral.